BOT:ASX
Botanix Pharmaceuticals Ltd
၀.၀၁၇ A$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၇, GMT+၁၁ ၁၆:၁၀:၀၇ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
၀.၀၂ A$
High
၀.၀၂ A$
Low
၀.၀၂ A$
Mkt. cap
၃.၉၈ ကုဋေ
Avg. vol.
၆.၀၅ သန်း
Volume
၁.၆၈ သန်း
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
Open
၀.၀၂ A$
High
၀.၀၂ A$
Low
၀.၀၂ A$
Mkt. cap
၃.၉၈ ကုဋေ
Avg. vol.
၆.၀၅ သန်း
Volume
၁.၆၈ သန်း
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
News stories
From web sources and news partners
Investing News Network
·
ပြီးခဲ့သည့် ၄၅ မိနစ်
Snorkel AI Raises $350 Million to Help Push the Frontier: NYSE Content Update
Quartz
·
ပြီးခဲ့သည့် ၁ နာရီ
Dow drops 451 points as Treasury yields hit 24-year highs
Seeking Alpha
·
ပြီးခဲ့သည့် ၅၉ မိနစ်
15 dividend stocks beating the S&P 500 as markets sit near record highs
CNBC
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500 record, ICE's economic chill, Webull's China ties and more in Morning Squawk
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd